Depo-Provera
These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959
199cf13e-0859-4a73-9b45-e700d0cd1049
HUMAN PRESCRIPTION DRUG LABEL
Dec 31, 2020
Pharmacia & Upjohn Company LLC
DUNS: 618054084
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
medroxyprogesterone acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
medroxyprogesterone acetate
Product Details
FDA regulatory identification and product classification information